3 months ago
CRBP
AnalystsJeff JonesJeff Jones's Stock Forecasts
AnalystsJeff Jones
Sectors:
Analyst Ranking
Top 11%
#501 out of 4565 analysts
Average Return
+20.9%
Win Rate
38%21 out of 55
Risk vs Reward
Poor
Good
Jeff Jones's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fusion Pharmaceuticals IncFUSN | +723.08% | $2.60 | $21.40 | 2023-09-28 - 2024-04-25 | Buy |
Corbus Pharmaceuticals Holdings IncCRBP | +444.72% | $6.15 | $33.50 | 2023-08-08 - 2024-04-25 | Buy |
Corbus Pharmaceuticals Holdings IncCRBP | +259.83% | $9.31 | $33.50 | 2023-05-09 - 2024-04-25 | Buy |
Prometheus Biosciences IncRXDX | +235.61% | $59.57 | $199.92 | 2022-10-03 - 2023-06-15 | Buy |
Perspective Therapeutics IncCATX | +229.22% | $0.49 | $1.60 | 2023-05-18 - 2024-04-25 | Buy |
Jeff Jones Analyst Color
Get additional color on Jeff Jones's coverage of popular stocks
Jeff Jones's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kymera Therapeutics IncKYMR | 1 | Buy | $53.00 | +58.92% | Initiates Coverage On | 5 days ago |
Zura Bio LtdZURA | 1 | Buy | $16.00 | +341.99% | Reiterates | 25 days ago |
Perspective Therapeutics IncCATX | 3 | Buy | $1.50 | -6.25% | Reiterates | 25 days ago |
Cellectar Biosciences IncCLRB | 2 | Buy | $12.00 | +297.35% | Reiterates | a month ago |
Corvus Pharmaceuticals IncCRVS | 1 | Buy | $7.00 | +372.97% | Maintains | a month ago |
Corbus Pharmaceuticals Holdings IncCRBP | 4 | Buy | $58.00 | +73.13% | Reiterates | a month ago |
Ventyx Biosciences IncVTYX | 7 | Buy | $12.00 | +195.57% | Upgrades | 2 months ago |
Seres Therapeutics IncMCRB | 2 | Buy | $5.00 | +572.95% | Maintains | 2 months ago |
Evolent Health IncEVH | 1 | Buy | $45.00 | +58.90% | Initiates Coverage On | 2 months ago |
Fusion Pharmaceuticals IncFUSN | 3 | Buy | $15.00 | -29.91% | Maintains | 4 months ago |
Pliant Therapeutics IncPLRX | 4 | Buy | $52.00 | +337.71% | Maintains | 9 months ago |
Cyclacel Pharmaceuticals IncCYCC | 3 | Buy | $120.00 | +7,400.00% | Maintains | a year ago |
Point Biopharma Global IncPNT | 2 | Buy | $13.00 | +4.00% | Reiterates | a year ago |
Novan IncNOVNQ | 2 | Buy | $8.00 | +8,410.64% | Maintains | a year ago |
Pmv Pharmaceuticals IncPMVP | 5 | Buy | $15.00 | +777.19% | Reiterates | a year ago |
Chemomab Therapeutics LtdCMMB | 3 | Buy | $7.00 | N/A | Maintains | a year ago |
An2 Therapeutics IncANTX | 1 | Buy | $24.00 | N/A | Maintains | a year ago |
Moleculin Biotech IncMBRX | 2 | Buy | $75.00 | N/A | Reiterates | a year ago |
Prometheus Biosciences IncRXDX | 6 | Buy | $150.00 | N/A | Maintains | a year ago |
Evaxion Biotech AEVAX | 2 | Buy | $110.00 | N/A | Maintains | a year ago |
Notable Labs LtdNTBL | 1 | Buy | $5.50 | N/A | Assumes | 2 years ago |
Rain Oncology IncRAIN | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.